SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom pope who wrote (10014)10/30/2008 12:58:46 AM
From: Qualified Opinion   of 10345
 
I haven't decided yet. You might want to listen to Elan's last earnings conference call for the optimistic side. I ignore EBITDA and seriously consider their interest expense. I think the Tysabri sales ramp, cash flow and news on the alzheimer's drug candidates will be important when Elan's debt matures in 2011 and 2013. For me, I reduce the aggravation of a position by scaling down the position to fit the risk.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News